vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and KULICKE & SOFFA INDUSTRIES INC (KLIC). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $199.6M, roughly 1.4× KULICKE & SOFFA INDUSTRIES INC). KULICKE & SOFFA INDUSTRIES INC runs the higher net margin — 8.4% vs 0.7%, a 7.7% gap on every dollar of revenue. On growth, KULICKE & SOFFA INDUSTRIES INC posted the faster year-over-year revenue change (20.2% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-11.6M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Kulicke & Soffa Industries Inc. is a leading global provider of semiconductor packaging and assembly equipment, materials, and process solutions. It serves semiconductor manufacturers across automotive electronics, consumer devices, industrial systems, and high-performance computing markets, with core offerings covering wire bonding and advanced packaging technologies.
HCM vs KLIC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $199.6M |
| Net Profit | $2.0M | $16.8M |
| Gross Margin | 37.7% | 49.6% |
| Operating Margin | -13.2% | 8.9% |
| Net Margin | 0.7% | 8.4% |
| Revenue YoY | -16.5% | 20.2% |
| Net Profit YoY | -83.6% | -79.4% |
| EPS (diluted) | $0.00 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $199.6M | ||
| Q4 25 | $270.8M | — | ||
| Q2 25 | $277.7M | — | ||
| Q1 25 | $324.5M | — | ||
| Q2 24 | $305.7M | — | ||
| Q2 23 | $532.9M | — | ||
| Q2 22 | $202.0M | — |
| Q1 26 | — | $16.8M | ||
| Q4 25 | $2.0M | — | ||
| Q2 25 | $455.0M | — | ||
| Q1 25 | $11.9M | — | ||
| Q2 24 | $25.8M | — | ||
| Q2 23 | $168.6M | — | ||
| Q2 22 | $-162.9M | — |
| Q1 26 | — | 49.6% | ||
| Q4 25 | 37.7% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q2 24 | 41.1% | — | ||
| Q2 23 | 0.0% | — | ||
| Q2 22 | 0.1% | — |
| Q1 26 | — | 8.9% | ||
| Q4 25 | -13.2% | — | ||
| Q2 25 | -1.3% | — | ||
| Q1 25 | -5.0% | — | ||
| Q2 24 | -9.0% | — | ||
| Q2 23 | 21.0% | — | ||
| Q2 22 | -97.4% | — |
| Q1 26 | — | 8.4% | ||
| Q4 25 | 0.7% | — | ||
| Q2 25 | 163.8% | — | ||
| Q1 25 | 3.7% | — | ||
| Q2 24 | 8.4% | — | ||
| Q2 23 | 31.6% | — | ||
| Q2 22 | -80.6% | — |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.00 | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.01 | — | ||
| Q2 24 | $0.03 | — | ||
| Q2 23 | $0.19 | — | ||
| Q2 22 | $-0.19 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $481.1M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $825.0M |
| Total Assets | $1.8B | $1.1B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $481.1M | ||
| Q4 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $836.1M | — | ||
| Q2 24 | $802.5M | — | ||
| Q2 23 | $856.2M | — | ||
| Q2 22 | $826.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | $93.2M | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q2 24 | $82.1M | — | ||
| Q2 23 | $40.1M | — | ||
| Q2 22 | $418.0K | — |
| Q1 26 | — | $825.0M | ||
| Q4 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $759.9M | — | ||
| Q2 24 | $740.1M | — | ||
| Q2 23 | $782.0M | — | ||
| Q2 22 | $799.7M | — |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $1.8B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q2 23 | $1.3B | — | ||
| Q2 22 | $1.2B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.08× | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q2 23 | 0.05× | — | ||
| Q2 22 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $-8.9M |
| Free Cash FlowOCF − Capex | $3.4M | $-11.6M |
| FCF MarginFCF / Revenue | 1.2% | -5.8% |
| Capex IntensityCapex / Revenue | 1.8% | 1.3% |
| Cash ConversionOCF / Net Profit | 4.21× | -0.53× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-8.9M | ||
| Q4 25 | $8.2M | — | ||
| Q2 25 | $-72.9M | — | ||
| Q1 25 | $40.3M | — | ||
| Q2 24 | $-39.8M | — | ||
| Q2 23 | $226.4M | — | ||
| Q2 22 | $-89.9M | — |
| Q1 26 | — | $-11.6M | ||
| Q4 25 | $3.4M | — | ||
| Q2 25 | $-82.2M | — | ||
| Q1 25 | $32.5M | — | ||
| Q2 24 | $-49.9M | — | ||
| Q2 23 | $202.0M | — | ||
| Q2 22 | $-105.6M | — |
| Q1 26 | — | -5.8% | ||
| Q4 25 | 1.2% | — | ||
| Q2 25 | -29.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q2 24 | -16.3% | — | ||
| Q2 23 | 37.9% | — | ||
| Q2 22 | -52.3% | — |
| Q1 26 | — | 1.3% | ||
| Q4 25 | 1.8% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 2.4% | — | ||
| Q2 24 | 3.3% | — | ||
| Q2 23 | 4.6% | — | ||
| Q2 22 | 7.8% | — |
| Q1 26 | — | -0.53× | ||
| Q4 25 | 4.21× | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q2 24 | -1.54× | — | ||
| Q2 23 | 1.34× | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
KLIC
| Ball Bonding Equipment Segment | $110.3M | 55% |
| Aftermarket Products And Services APS Segment Post Cessation | $45.1M | 23% |
| Wedge Bonding Equipment Segment | $21.1M | 11% |
| Automotiveand Industrial | $13.6M | 7% |
| All Others Segment | $11.4M | 6% |
